thioridazine has been researched along with Leukemia P388 in 1 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuwano, M | 1 |
| Nakagawa, M | 1 |
| Shiraishi, N | 1 |
| Yamaguchi, T | 1 |
| Kikuchi, J | 1 |
| Akiyama, S | 1 |
1 other study available for thioridazine and Leukemia P388
| Article | Year |
|---|---|
Techniques to reverse or circumvent drug-resistance in vitro.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Butadienes; Calcium Channel Blockers; Calmodulin; Ce | 1986 |